File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Reply to: “ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative patients receiving Peg-IFNα based therapy”

TitleReply to: “ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative patients receiving Peg-IFNα based therapy”
Authors
Hui, Rex Wan HinMak, Lung YiYuen, Man Fung
Issue Date1-May-2025
PublisherElsevier
Citation
Journal of Hepatology, 2025, v. 82, n. 5, p. e228-e229 How to Cite?
DOI: http://dx.doi.org/10.1016/j.jhep.2024.12.036
Persistent Identifierhttp://hdl.handle.net/10722/359609
ISSN
0168-8278
2023 Impact Factor: 26.8
2023 SCImago Journal Rankings: 9.857

 

DC FieldValueLanguage
dc.contributor.authorHui, Rex Wan Hin-
dc.contributor.authorMak, Lung Yi-
dc.contributor.authorYuen, Man Fung-
dc.date.accessioned2025-09-09T00:45:29Z-
dc.date.available2025-09-09T00:45:29Z-
dc.date.issued2025-05-01-
dc.identifier.citationJournal of Hepatology, 2025, v. 82, n. 5, p. e228-e229-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/359609-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofJournal of Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleReply to: “ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative patients receiving Peg-IFNα based therapy”-
dc.typeArticle-
dc.identifier.doi10.1016/j.jhep.2024.12.036-
dc.identifier.pmid39725353-
dc.identifier.scopuseid_2-s2.0-85219715942-
dc.identifier.volume82-
dc.identifier.issue5-
dc.identifier.spagee228-
dc.identifier.epagee229-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats